Incidence and risk factors for treatment failure with infliximab in psoriasis

Saved in:

Bibliographic Details
Published in	Journal of the European Academy of Dermatology and Venereology Vol. 27; no. 10; pp. 1323 - 1324
Main Authors	Escande, H., Livideanu, C. Bulai, Steiner, A., Lahfa, M., Marguery, M.C., Mazereeuw, J.H., Meyer, N., Labadie, F.G., Aquilina, C., Viraben, R., Gourraud, P.A., Paul, C.
Format	Journal Article
Language	English
Published	England Blackwell Publishing Ltd 01.10.2013
Subjects	Antibodies, Monoclonal - therapeutic use Dose-Response Relationship, Drug Female Humans Incidence Infliximab Kaplan-Meier Estimate Male Psoriasis - drug therapy Retrospective Studies Risk Factors Treatment Failure
Online Access	Get full text

Loading…

More Information
Bibliography:	istex:0DF1043365265688A59A8F9B7B51E36C7B787177 ark:/67375/WNG-9J4H42MJ-Q ArticleID:JDV12077 SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1
ISSN:	0926-9959 1468-3083
DOI:	10.1111/jdv.12077